Correlation Between Evoke Pharma and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Neurocrine Biosciences, you can compare the effects of market volatilities on Evoke Pharma and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Neurocrine Biosciences.
Diversification Opportunities for Evoke Pharma and Neurocrine Biosciences
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Evoke and Neurocrine is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Evoke Pharma and Neurocrine Biosciences
Given the investment horizon of 90 days Evoke Pharma is expected to generate 2.67 times more return on investment than Neurocrine Biosciences. However, Evoke Pharma is 2.67 times more volatile than Neurocrine Biosciences. It trades about 0.16 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.34 per unit of risk. If you would invest 441.00 in Evoke Pharma on November 9, 2024 and sell it today you would earn a total of 44.00 from holding Evoke Pharma or generate 9.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evoke Pharma vs. Neurocrine Biosciences
Performance |
| Timeline |
| Evoke Pharma |
| Neurocrine Biosciences |
Evoke Pharma and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evoke Pharma and Neurocrine Biosciences
The main advantage of trading using opposite Evoke Pharma and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |